Searching for smart, safe news you can TRUST?
Support safe, smart, REAL journalism. Sign up for our Axios AM & PM newsletters and get smarter, faster.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Denver news in your inbox
Catch up on the most important stories affecting your hometown with Axios Denver
Des Moines news in your inbox
Catch up on the most important stories affecting your hometown with Axios Des Moines
Minneapolis-St. Paul news in your inbox
Catch up on the most important stories affecting your hometown with Axios Twin Cities
Tampa Bay news in your inbox
Catch up on the most important stories affecting your hometown with Axios Tampa Bay
Charlotte news in your inbox
Catch up on the most important stories affecting your hometown with Axios Charlotte
Photo credit should read Josh Edelson/AFP/Getty Images
Bayer stock fell more than 10% on Monday, representing a loss of more than $10 billion in market cap, on the first day of trading after a California jury found that the German company owed $289.2 million to a man who claims to have gotten cancer from exposure to Roundup weed killer.
The bottom line: Bayer might have taken on a bigger liability than it realized in buying Roundup maker Monsanto, via a $64 billion merger that closed this past June, as this could be just the first of thousands of similar lawsuits.